Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein.
about
Acceleration of plasminogen activation by tissue plasminogen activator on surface-bound histidine-proline-rich glycoproteinIdentification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R)Studies of binding of prekallikrein and Factor XI to high molecular weight kininogen and its light chainFactor XI and contact activation as targets for antithrombotic therapyFactor XI Deficiency Alters the Cytokine Response and Activation of Contact Proteases during Polymicrobial Sepsis in MiceHeat shock protein 90 catalyzes activation of the prekallikrein-kininogen complex in the absence of factor XII.Initiation of plasma prorenin activation by Hageman factor-dependent conversion of plasma prekallikrein to kallikreinCombined cis-regulator elements as important mechanism affecting FXII plasma levelsCleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.A novel DFP tripeptide motif interacts with the coagulation factor XI apple 2 domainThe autoactivation of rabbit Hageman factor.Dissemination of contact activation in plasma by plasma kallikrein.Chemotactic activity generated from the fifth component of complement by plasma kallikrein of the rabbit.Localization of the membrane attack complex (MAC) in experimental immune complex glomerulonephritis.Kininogen deficiency protects from ischemic neurodegeneration in mice by reducing thrombosis, blood-brain barrier damage, and inflammation.P1 and P2' site mutations convert protease nexin-2 from a factor XIa inhibitor to a plasmin inhibitorThe hemostasis system in murine atherosclerosis.Activation of rabbit Hageman factor by homogenates of cultured rabbit endothelial cells.Characterization of a heparin-binding site on the catalytic domain of factor XIa: mechanism of heparin acceleration of factor XIa inhibition by the serpins antithrombin and C1-inhibitorInhibitory spectrum of alpha 2-plasmin inhibitor.Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII).Kinetic analysis of the interaction of human tissue kallikrein with single-chain human high and low molecular weight kininogensSingle-chain factor XII: a new form of activated factor XII.Interaction of the clotting, kinin-forming, complement, and fibrinolytic pathways in inflammation.Activation of the kinin-forming cascade on the surface of endothelial cells.Relation between structure and correcting activity of bovine high molecular weight kininogen upon the clotting time of Fitzgerald-trait plasma.Platelet-coagulant protein interactions in contact activation.A putative transmembrane protein with histidine-rich charge clusters encoded in the H-2K/tw5 region of mice.Surface and fluid phase activities of two forms of activated Hageman factor produced during contact activation of plasma.An update on factor XI structure and function.Identification of proteins adsorbed to hemodialyser membranes from heparinized plasma
P2860
Q24313110-F91D4DFD-5A01-4806-BB1C-4F1E30B5F233Q24313325-B178DAD8-D08B-407E-959B-7EBD6D2BC177Q24564856-B558C3CF-35EA-4A11-9DE0-FD06E5B86672Q27024190-74053DE3-9706-4E44-B81C-B4EEDD59EC1DQ27314976-E6DAC67C-599A-43A2-9A6C-83917D0489E1Q33894624-6AA0DA08-68DF-4050-91BC-FB175A49F85DQ33982766-DF602B79-B41F-4890-8FCA-B3FC3CC650F4Q34003352-742D0AA1-73E1-4F79-BA4D-F5EA5B1A6A97Q34607071-77C574F9-6496-45F8-A2A3-FA9ACF47AC2DQ35967104-E23409FE-542E-4E90-A902-B425B3E9127EQ36342996-F4BA875C-E986-4AF8-9EA5-B7134CA63C8DQ36343908-2E56451A-8349-4AC9-876B-29F596C0919BQ36344869-872A3B7B-6AA0-47AA-A248-0D959E50009FQ36347889-E2B21BA2-2922-4007-9E0B-DCF1568FB355Q36528998-A38F45E6-B170-462F-9B49-78FC6D4868A2Q36562568-1CEF4AE5-BD39-40F7-8BBA-361C83C4261CQ36893444-DFDEC350-9291-4CCD-9796-8FF1621A9F41Q37019645-BE3DC276-DCF6-49F6-B78E-6D3057F62B2EQ37125600-80EFD7A1-202F-45CD-9AB9-D3FCF0D8A428Q37328778-43DD700F-BBEB-4A89-928A-6966234BE9BCQ37584724-5B5CAB8C-FA9C-4E37-A9CD-39A67DECF1C8Q37616021-B6279C32-78F6-4557-B637-40E4D6006EBBQ39366435-2A76D7BE-6E3B-4F14-9F19-AE243B63A07EQ40333596-184F53D8-133D-4AE1-AD73-08036CD8B810Q40819973-C8211C54-C7F8-48FC-AC62-4811B255F2F3Q41503894-7F2FE319-CFA0-49BC-8C3A-4C22558C0FD0Q41616250-A0F8C5FD-1C6D-4FEB-B315-F7DC9E7B2EF0Q41750727-91BA406D-5269-4195-AA4F-CF470AEC3A24Q41814564-68375BA7-68B6-4577-A320-6159D15497A3Q47311661-00EDE62E-B797-4400-8210-B4BDAC989840Q56963845-EC4CB910-090F-4C8E-90CD-7D5048836DF6
P2860
Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein.
description
1977 nî lūn-bûn
@nan
1977 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1977 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
name
Role of high-molecular-weight ...... n Factor XI and prekallikrein.
@ast
Role of high-molecular-weight ...... n Factor XI and prekallikrein.
@en
type
label
Role of high-molecular-weight ...... n Factor XI and prekallikrein.
@ast
Role of high-molecular-weight ...... n Factor XI and prekallikrein.
@en
prefLabel
Role of high-molecular-weight ...... n Factor XI and prekallikrein.
@ast
Role of high-molecular-weight ...... n Factor XI and prekallikrein.
@en
P2093
P2860
P356
P1476
Role of high-molecular-weight ...... n Factor XI and prekallikrein.
@en
P2093
Cochrane CG
Griffin JH
Wiggins RC
P2860
P304
P356
10.1073/PNAS.74.10.4636
P407
P577
1977-10-01T00:00:00Z